Abstract S73 Table 1

Demographic data, evidence of sensitisation and clinical parameters

2001–2002 study1 2009–2011 study1 2015–2016 study
VirusNumber tested (percentage positive)<5 years5–16 yearsNumber tested (percentage positive)<5 years5–16 yearsNumber tested (percentage positive)<5 years5–16 yearsFrequency change (2009–2011 study to 2015–2016 study)
RSV213 (15.0%)293147 (21.1%)301147 (10.2%)150p = 0.015
Influenza A and B viruses213 (6.1%)94149 (12.1%)117147 (10.2%)123p = 0.713
- H1N1 NT NT 141 (5.0%) 4 3 147 (4.8%) 6 1 p = 1
Adenovirus213 (6.1%)112145 (6.9%)100147 (10.2%)114p = 0.404
Parainfluenza 1–4158 (3.2%)50141 (4.3%)51147 (6.1%)90p = 0.599
Human metapneumovirus48 (0%)00141 (0.7%)10147 (3.4%)50p = 0.214
RhinovirusNot testedNTNT141 (8.5%)102147 (7.5%)83p = 0.829
Total54967116010
  • NT = not tested, note: children with bronchiolitis were excluded